FDA Inspection 1080428 — NewYork-Presbyterian/Weill Cornell Medical Center
The FDA completed an inspection of NewYork-Presbyterian/Weill Cornell Medical Center on February 7, 2019 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 7, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New York, NY (United States)